KERATINOUS MATERIAL CARE COMPOSITION
A composition with a defined ratio of liquid solvents and fatty acid/ester mixtures addresses skin itching and odor issues, offering effective soothing and pleasant scent.
Patent Information
- Application Number
- FR2023006203
- Authority / Receiving Office
- FR · FR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-04-28
- Filing Date
- 2023-06-16
- Publication Date
- 2024-11-01
AI Technical Summary
Existing cosmetic compositions fail to effectively soothe skin itching sensations while avoiding unpleasant odors.
A composition comprising a specific ratio of liquid solvents (monoalcohols, diols, and diol ethers) and a mixture of fatty acids and esters, including medium-chain fatty acids and polyol monoesters, is formulated to provide skin soothing without noticeable odor.
The composition effectively alleviates skin itching and maintains a pleasant odor profile, enhancing user comfort and satisfaction.
Abstract
Description
Title of the invention: KERATINOUS MATERIAL CARE COMPOSITION technical field
[0001] The present invention relates to a cosmetic composition. In particular, the present invention relates to a composition for the care of keratinous materials. The present invention also relates to a non-therapeutic method for the care of keratinous materials. STATE OF THE ART
[0002] Keratinous materials are widely present on the surface of human bodies, for example, the skin, scalp, and hair. Many people have long sought to soothe the surface of their bodies in order to feel comfortable in daily life and at work. Among other things, the sensation of itching is particularly prevalent. Various factors can cause itching, for example, excessive dryness of the body surface, the presence of certain bacteria on the body surface, allergies, external stimuli, or even psychological factors, etc. Consequently, various products are developed to treat itching, many of which are used to soothe the sensation of itching.In particular, considering the various factors, alleviating the sensation of skin itching is usually more feasible and significant than therapeutic treatment directly targeting the factors.
[0003] With regard to the care compositions of keratinous materials, certain other properties, for example, the absence of unpleasant odor, are also important to attract consumers.
[0004] Thus, there is a need to develop a keratinous material care composition that can be used to soothe the sensation of itching of the skin and does not deliver an obvious unpleasant odor. Summary of the invention
[0005] The inventors have now discovered that at least one of the above requirements can be met by the present invention.
[0006] Consequently, in a first aspect, the present invention proposes a composition for the care of keratinous materials, comprising: a. at least one liquid solvent selected from monoalcohols containing 6 or more carbon atoms, diols containing 4 or more carbon atoms, and diol ethers containing 4 or more carbon atoms; and b. a mixture of fatty acid and ester comprising i. a fatty acid component comprising at least 3 medium-chain fatty acids, and, ii. an ester component comprising at least 3 medium-chain fatty acid monoesters with a polyol,
[0007] in which the weight ratio between the liquid solvent and the fatty acid and ester mixture is greater than 1.5:1 and less than 25:1.
[0008] The inventors have discovered that the composition of the present invention can be used to soothe the sensation of itchy skin and does not deliver any obvious unpleasant odor.
[0009] In a second aspect, the present invention proposes a non-therapeutic method for the treatment of keratinous materials, comprising the application of the composition according to the first aspect of the present invention to the keratinous materials.
[0010] Other subjects and features, aspects and advantages of the present invention will become even clearer upon reading the detailed description and examples that follow. DETAILED DESCRIPTION OF THE INVENTION
[0011] Unless otherwise defined, all technical and scientific terms used herein have the same meaning as that commonly understood by a person skilled in the art in the field covered by the present invention. Where the definition of a term in the present invention conflicts with the meaning commonly understood by a person skilled in the art in the field covered by the present invention, the definition described in the present invention shall apply.
[0012] In what follows and unless otherwise indicated, the limits of a range of values are included within that range, in particular in the expressions "between...and..." and "from...to...".
[0013] Moreover, the expression "at least one" used in this description is equivalent to the expression "one or more".
[0014] Throughout this application, the term "comprising" shall be interpreted as encompassing all the specifically mentioned features as well as any optional, additional, and unspecified features. As used herein, the use of the term "comprising" also discloses the embodiment in which no features other than the specifically mentioned features are present (i.e., "consisting of").
[0015] Unless otherwise specified, all numerical values expressing a quantity of ingredients and the like used in the description and claims shall be understood as modified by the term "approximately". Accordingly, unless otherwise stated, the numerical values and parameters described These are approximate values that can be changed depending on the desired objective, if applicable.
[0016] For the purposes of the present invention, the term "keratinous materials" is intended to cover human skin and mucous membranes such as the lips. The scalp is specifically considered in the present invention.
[0017] In the present invention, all percentages refer, unless otherwise specified, to a percentage by weight.
[0018] The composition according to the present invention comprises: a. at least one liquid solvent selected from monoalcohols containing 6 or more carbon atoms, diols containing 4 or more carbon atoms, and diol ethers containing 4 or more carbon atoms; and a. a mixture of fatty acid and ester comprising i. a fatty acid component comprising at least 3 chain fatty acids average, and, i. an ester component comprising at least 3 medium-chain fatty acid monoesters with a polyol,
[0019] in which the weight ratio between the liquid solvent and the fatty acid and ester mixture is greater than 1.5:1 and less than 25:1. Liquid solvents
[0020] According to the first aspect, the composition of the present invention comprises at least one liquid solvent selected from monoalcohols containing 6 or more carbon atoms, diols containing 4 or more carbon atoms, and diol ethers containing 4 or more carbon atoms.
[0021] The expression "liquid solvent" means that the solvent is capable of flowing under its own weight, at room temperature (20 °C) and atmospheric pressure (760 mmHg).
[0022] As used here, monoalcohols refer to alcohols comprising a single hydroxyl group.
[0023] Examples of suitable monoalcohols for the composition according to the present invention include octyldodecanol, isostearyl alcohol and ethoxydiglycol.
[0024] As used here, diols refer to alcohols comprising two hydroxyls.
[0025] Examples of diols suitable for the composition according to the present invention include butylene glycol, pentylene glycol, hexylene glycol and caprylyl glycol.
[0026] As used here, diols ethers refer to ethers formed by diols.
[0027] Examples of diol ethers suitable for the composition according to the present invention include dipropylene glycol and diethylene glycol.
[0028] Preferably, the liquid solvent is chosen from caprylyl glycol, hexylene glycol, dipropylene glycol, octyldodecanol, isostearyl alcohol, ethoxydiglycol and their combination.
[0029] More preferably, the liquid solvent is chosen from octyldodecanol, dipropylene glycol, hexylene glycol, caprylyl glycol and their combination.
[0030] Advantageously, the liquid solvent present in the composition according to the present invention in an amount ranging from more than 5% by weight to 80% by weight, relative to the total weight of the composition. Mixture of fatty acids and esters
[0031] According to the first aspect, the composition of the present invention comprises a mixture of fatty acid and ester comprising i. a fatty acid component comprising at least 3 medium-chain fatty acids, and, i. an ester component comprising at least 3 medium-chain fatty acid monoesters with a polyol.
[0032] The expression "mixture of fatty acid and ester" here means a mixture of one or more fatty acids and one or more esters.
[0033] The fatty acid and ester mixture may comprise: i. a fatty acid component comprising at least 3, 4 or 5 medium-chain fatty acids; and i. an ester component comprising at least 3, 4 or 5 of the medium chain fatty acid monoesters with a polyol.
[0034] The monoester in the ester component may be monoesters of medium-chain fatty acids with a lower polyol such as glycerol.
[0035] The medium-chain fatty acid can be a monocarboxylic acid having 6 to 20 carbon atoms, preferably 8 to 16 carbon atoms, and more preferably 8 to 12 carbon atoms.
[0036] The medium-chain fatty acid can be represented by the following formula (I):
[0037] RC(O)-OH (I)
[0038] in which
[0039] R represents a linear or branched hydrocarbon group, saturated or unsaturated in C5-Ci9, preferably in C7-Ci5, and more preferably in C7-Cn such as an alkyl group; preferably, R is a linear hydrocarbon group; and more preferably, R is a linear alkyl group.
[0040] According to some embodiments, R may have an odd number, for example, 5, 7, 9, 11, 13, 15, 17 or 19, of carbon atoms. Preferably, R may have 7, 9, 11, 13 or 15 carbon atoms; and more preferably, R may have 7, 9 or 11 carbon atoms.
[0041] Preferably, the medium-chain fatty acid according to formula (I) can be caprylic acid (C8), also called octoic acid, capric acid (C10), lauric acid (C12), myristic acid (CM), palmitic acid (C16), stearic acid (C[8] or arachidic acid (C20).
[0042] The medium-chain fatty acid can be at least partially esterified with a polyol.
[0043] According to certain embodiments, the monoester used in the monoester component can be a monoester represented by the following formula (II):
[0044] RC(O)-OR' (II)
[0045] in which
[0046] R is such that defined in formula (I), and
[0047] R' represents a residue of a polyol.
[0048] The polyol may contain from 2 to 20 carbon atoms, preferably from 2 to 10 carbon atoms, and more preferably from 2 to 6 carbon atoms. The useful polyol may be glycerol, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, dipropylene glycol, or diethylene glycol.
[0049] Preferably in formula (II), R and R' are different from each other, in which R represents a linear C7-C15 alkyl, and R' represents a residue of a linear polyol containing 2 to 6 carbon atoms.
[0050] According to the present invention, the medium chain fatty acid according to formula (I) is preferably used in combination with the monoester according to formula (II), so as to form the fatty acid and ester mixture.
[0051] Preferably, the medium-chain fatty acid and the monoester for the fatty acid-ester mixture involve the same fatty acid fraction, i.e., the medium-chain fatty acid of formula (I) and the monoester of formula (II) have the corresponding R group. That is, if a medium-chain fatty acid of formula (I) having heptyl as R, i.e., being caprylic acid, is used, then a monoester of formula (II) having heptyl as R, i.e., being a caprylic acid monoester, is used to form the fatty acid-ester mixture. Similarly, if two or more fatty acids are used simultaneously for the fatty acid-ester mixture, then the two or more corresponding monoesters having the same fatty acid fractions are used.In other words, according to certain embodiments, the fatty acid and ester mixture can be considered as a mixture of three or more fatty acids of formula (I) and partially esterified monoesters of each fatty acid.
[0052] According to certain embodiments, the fatty acid and ester mixture comprises at least 3, 4 or 5 of the medium-chain fatty acids of formula (I) and the monoesters of formula (II) having the corresponding R groups respectively identical to the acids Medium-chain fatty acids of formula (II). For medium-chain fatty acid fractions, it is preferable to use the same polyol to form the monoesters. That is, for the two other monoesters of formula (II) in the fatty acid and ester mixture, they have the same R' group. Among others, glycerol is particularly used to form glycerides with the aforementioned medium-chain fatty acids, corresponding to varying degrees.
[0053] According to certain embodiments, for example, the fatty acid and ester mixture comprises at least three fatty acids selected from the group consisting of caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid, and arachidic acid, to be used as the fatty acid component. Meanwhile, the corresponding monoesters of each fatty acid in the fatty acid component are used as the monoester component. Preferably, the monoesters of the monoester component are each a glyceride.
[0054] Preferably, the fatty acid component comprises caprylic acid, capric acid, and lauric acid. Conversely, the corresponding monoester component comprises a caprylic glyceride (also called monocaprylin), a capric glyceride (also called monocaprine), and a lauric glyceride (also called monolaurin).
[0055] Preferably, with regard to the mixture of fatty acid and ester, the fatty acid component and the monoester component, for example the glycerides thereof, are present in a weight ratio of 4:1 to 1:1, preferably 3:1 to 1:1, and more preferably 2.5:1 to 1.5:1.
[0056] According to certain embodiments, for example, the fatty acid and ester mixture can be obtained by directly partially esterifying the fatty acid component with a polyol to form monoesters, thereby obtaining a mixture of fatty acids and the corresponding monoesters as a monoester component. Since a polyol is used, it is understood that a multiester, for example a diester, a triester, etc., can ultimately be formed. Consequently, a fatty acid and ester mixture comprising at least three fatty acids, monoesters corresponding to at least three fatty acids, and multiesters corresponding to at least three medium-chain fatty acids, is always useful within the meaning of the present invention.
[0057] For the purposes of the present invention, the term "multiester" is provided to designate an ester formed by the esterification of a polyol, in which more than one hydroxyl group of a polyol molecule is esterified. Accordingly, "diester" or "triester" according to the present invention designates, respectively, an ester in which two or three hydroxyl groups of a polyol molecule are esterified.
[0058] For example, when glycerol is used to esterify the fatty acid component, the mixture of fatty acid and useful ester may comprise at least 3 fatty acids, mo noesters, diesters and triesters corresponding to at least 3 fatty acids. For example, the useful fatty acid and ester mixture may include caprylic acid, capric acid and lauric acid, as fatty acid component; monocaprylin, monocaprine and monolaurin, as monoester component; and a diglyceride and a triglyceride of caprylic acid, capric acid and lauric acid.
[0059] When the fatty acid and ester mixture also includes a multiester, the content of the multiester is not particularly limited. For example, the multiester may be used in the fatty acid and ester mixture in an amount of up to 90% by weight, preferably 80% by weight or less, more preferably 70% by weight or less, and even more preferably 65% by weight or less. (AVCO)
[0060] According to some embodiments, for example, the mixture of fatty acid and ester may be of natural origin. Among others, it is quite well known that coconut oil comprises a mixture of various C8-C2o fatty acids, in particular those having an even number of carbon atoms.
[0061] Thus, it is desirable for the present invention to use coconut oil or a coconut oil derivative, for example, an esterified coconut oil product, as a mixture of fatty acid and ester.
[0062] Among others, a useful derivative of coconut oil is that called activated virgin coconut oil (AVCO). Preferably, the coconut oil is esterified with glycerol. A useful AVCO according to the present invention may comprise caprylic acid, capric acid, and lauric acid as fatty acid components; and monocaprylin, monocaprine, and monolaurin as monoester components.
[0063] According to one embodiment of the present invention, as a useful AVCO, the fatty acids in the fatty acid component and the monoglycerides in the monoester component are present in a weight ratio from 4:1 to 1:1, preferably from 3:1 to 1:1, and more preferably from 2.5:1 to 1.5:1.
[0064] More specifically, for example, in an example embodiment for the AVCO, a useful AVCO may include: i) a fatty acid component comprising: caprylic acid in an amount of 5 to 20% by weight, preferably 7 to 15% by weight, and more preferably 8 to 10% by weight; capric acid in an amount of 1 to 10% by weight, preferably 2 to 8% by weight and more preferably 4 to 7% by weight; and lauric acid in an amount of 20 to 70% by weight, preferably 30 to 60% by weight, and more preferably 40 to 55% by weight, and ii) a monoester component comprising: monocaprylin in an amount of 0.5 to 15% by weight, preferably 1 to 10% by weight, and more preferably 4 to 7% by weight; monocaprin in an amount of 0.1 to 10% by weight, preferably 1 to 8% by weight, and more preferably 3 to 5% by weight; and monolaurin in an amount of 10 to 40% by weight, preferably 15 to 35% by weight, and more preferably 20 to 30% by weight; each in relation to the total amount of the fatty acid component and the monoester component.
[0065] An AVCO obtained from the esterification of coconut oil may further comprise a diglyceride and a triglyceride in addition to the fatty acid component and the monoester component mentioned above. According to one embodiment of the present invention, for example, a useful AVCO may comprise caprylic acid, capric acid, and lauric acid as fatty acid components; monocaprylin, monocaprine, and monolaurin as monoester components; and optionally a diglyceride and a triglyceride of caprylic acid, capric acid, and lauric acid.
[0066] When the AVCO also comprises a multiester selected from diglycerides and triglycerides, the content of the multiester is not particularly limited, for example, to an amount of up to 90% by weight, preferably 80% by weight or less, more preferably 70% by weight or less, and even more preferably 65% by weight or less, each with respect to the total amount of the AVCO.
[0067] According to one embodiment of the present invention, for example, a useful AVCO may comprise: i) a fatty acid component comprising caprylic acid, capric acid and lauric acid, in an amount of 5 to 40% by weight, preferably 10 to 30% by weight, and more preferably 20 to 25% by weight; ii) a monoester component comprising monocaprylin, monocaprine and monolaurin, in an amount of 1 to 30% by weight, preferably 5 to 20% by weight, and more preferably 10 to 15% by weight; iii) a diester component comprising diglycerides of caprylic acid, capric acid and lauric acid, in an amount of 10 to 50% by weight, preferably 20 to 45% by weight, and more preferably 30 to 40% by weight;and iv) a triester component comprising caprylic acid, capric acid and lauric acid triglycerides, in an amount of 10 to 70% by weight, preferably 15 to 50% by weight, and more preferably 20 to 30% by weight; each relative to the total amount of AVCO.
[0068] A useful AVCO may preferably be an AVCO prepared according to the teachings of EP 1973415, which is incorporated herein by reference. Accordingly, an example of an AVCO may include: 24.63 mg / g caprylic acid (C8), 17.81 mg / g capric acid (C10), 133.70 mg / g lauric acid (C12), and 11.82 mg / g monocaprylin, 8.29 mg / g monocaprine, and 57.16 mg / g monolaurin; or 23.10 mg / g of caprylic acid (C8), 16.08 mg / g of capric acid (C10), 116.81 mg / g of lauric acid (C12) and 16.04 mg / g of monocaprylin, 10.35 mg / g of monocaprine and 75.54 mg / g of monolaurin; each relative to the total weight of the AVCO; and preferably, the AVCO is derived from the catalysis of coconut oil with specific 1,3-lipase and its submission to glycerolysis.
[0069] A commercial product may be used as an AVCO. An example of a commercially available AVCO is the AVCO (INCI name: Cocos Nucifera Oil (coconut)) marketed by Biotropics.
[0070] Advantageously, the fatty acid and ester mixture is present in the composition according to the present invention in an amount ranging from 1.2% by weight to 80% by weight, preferably from 2% by weight to 60% by weight, more preferably from 3% by weight to 30% by weight, relative to the total weight of the composition.
[0071] Advantageously, the weight ratio between the liquid solvent and the fatty acid and ester mixture is from 1.6:1 to 20:1, preferably from 1.6:1 to 15:1. Water
[0072] The cosmetic composition of the present invention may further include water.
[0073] Advantageously, water is present in the composition of the present invention in an amount ranging from 40% by weight to 88% by weight, preferably from 50% by weight to 80% by weight, relative to the total weight of the composition. Additional cosmetic active ingredients
[0074] The composition of the present invention may include an additional cosmetic active ingredient in addition to the fatty acid and ester mixture as defined above.
[0075] Examples of cosmetic active ingredients include moisturizing agents; vitamins; firming agents; agents acting on microcirculation and mixtures thereof.
[0076] It is easy for a person skilled in the art to adjust the quantity of the additional cosmetic active ingredient according to the final use of the composition according to the present invention. Adjuvants or additives
[0077] The composition of the present invention may also include conventional cosmetic adjuvants or additives, for example, perfumes, antioxidants, chelating agents, preservatives, thickeners, emulsifiers, pH regulators and mixtures thereof.
[0078] A person skilled in the art can choose the quantity of adjuvants or additives so as not to have a negative impact on the final use of the composition according to the present invention.
[0079] According to a particularly preferred embodiment, the present invention proposes a keratin treatment composition comprising, relative to the total weight of the composition: a. 20% by weight to 80% by weight of a liquid solvent selected from octyldodecanol, dipropylene glycol, hexylene glycol, caprylyl glycol and combinations thereof; and a. from 3% by weight to 30% by weight of an activated virgin coconut oil comprising, relative to the total quantity of activated virgin coconut oil: i. 20 to 25% by weight of a fatty acid component comprising caprylic acid, capric acid and lauric acid; i. 10 to 15% by weight of a monoester component comprising mono-caprylin, monocaprine and monolaurin; ii. 30 to 40% by weight of a diester component comprising diglycerides of caprylic acid, capric acid and lauric acid; and iii. 20 to 30% by weight of a triester component comprising caprylic acid, capric acid and lauric acid triglycerides,
[0080] in which the weight ratio between the liquid solvent and the fatty acid and ester mixture is greater than 1.6:1 and less than 15:1. pharmaceutical form and process
[0081] The composition of the present invention is in the form of a liquid, lotion, emulsion or serum.
[0082] The composition of the present invention can be used for the care of keratinous materials.
[0083] According to the second aspect, the present invention proposes a non-therapeutic method for the treatment of keratinous materials, comprising the application of the composition according to the present invention to the keratinous materials.
[0084] In particular, keratinous material is the skin, for example, the scalp. EXAMPLES
[0085] The following examples serve to illustrate the present invention without, however, being limiting in nature.
[0086] The main raw materials used, trade names and their suppliers are listed in Table 1.
[0087] [Tables 1] INCI name Trade name Supplier Dipropylene glycol DIPROPYLENE GLYCOL DONGYING HI-TECH SPRING CHEMICAL IN Cocos nucifera (coconut) oil ACTIVATED VIRGIN COCONUT OIL BIOTROPICS Octyldodecanol EUTANOL® G BASF Hydrogenated lecithin NIKKOL LECINOL S-10 NIKKO Carbomer ACRYPOL® 980 COREL PHARMA CHEM Ammonium polyacryloyl-dimethyl taurate HOSTACERIN® AMPS CLARIANT Dicaprylyl carbonate CETIOL® CC BASF Squalane EXOLIVE® CAROI LINE COSMETICA
[0088] Inventive Examples 1 and 2 and Comparative Examples 1 to 4
[0089] The compositions of Inventive Examples (EI) 1 and 2 and Comparative Examples (CE) 1 to 4 were prepared on the basis of the quantities given in Table 2. The quantities are given as % by weight of each component relative to the total weight of the composition.
[0090] [Tables2] Components ELI EL2 EC. 1 EC. 2 EC.3 EC. 4 Cocos nucifera (coconut) oil 20 30 81 85 20 20 Dipropylene glycol 80 / 19 / / / Octyldodecanol / 70 / 15 / / Dicaprylyl carbonate / / / / 80 / Squalane / / / / / 80
[0091] The composition of Inventive Examples 1 and 2 represents compositions according to the present invention.
[0092] The composition of Comparative Example 1 comprises a liquid solvent and a mixture of fatty acid and ester in a weight ratio of less than 1.5:1.
[0093] The composition of Comparative Example 2 comprises a liquid solvent and a mixture of fatty acid and ester in a weight ratio of less than 1.5:1.
[0094] The composition of Comparative Example 3 comprises 80% by weight of dicaprylyl carbonate instead of the liquid solvent according to the present invention, relative to the total weight of the composition.
[0095] The composition of Comparative Example 4 comprises 80% by weight of squalene instead of the liquid solvent according to the present invention, relative to the total weight of the composition.
[0096] Preparation process:
[0097] The compositions comprising the components listed in Table 2 were prepared by mixing the ingredients contained therein and shaking them thoroughly. Evaluation
[0098] The odor of each composition obtained was evaluated by nose by an odor expert and classified according to the following standard:
[0099] Unpleasant: The rancid odor of the composition is easily perceptible when a human nose is 3 cm from the sample. And the odor disappears when the distance between the nose and the sample is greater than 5 cm.
[0100] Passable: the rancid odor of the composition is barely perceptible when a human nose is 3 cm from the sample.
[0101] Good: the rancid odor of the composition is barely perceptible when a human nose is 2 cm from the sample.
[0102] Excellent: the rancid odor of the composition is barely perceptible when a human nose is 1 cm from the sample.
[0103] The evaluation results of each composition tested have been summarized in Table 3.
[0104] [Tables3] ELI EL2 EC. 1 EC. 2 EC. 3 EC. 4 Odor evaluation by nose Excellent Excellent Poor Poor Poor Poor
[0105] It can be seen in Table 3 that the rancid odor of the composition is barely perceptible for the compositions of Inventive Examples 1 and 2. Inventive Examples 3 to 6 and Comparative Example 5
[0106] The compositions of Inventive Examples (EI) 3 to 6 and Comparative Example (CE) 5 were prepared on the basis of the quantities given in Table 2. The quantities are given as % by weight of each component relative to the total weight of the composition.
[0107]
[0108]
[0109]
[0110] [YES] [Tables 4] Components EI.3 EI.4 EI.5 EL 6 EC.5 Demineralized water QS QS QS QS QS Cocos nucifera (coconut) oil 3 3 3 3 3 Dipropylene glycol 20 40 / 20 / Octyldodecanol / / 5 5 / Hydrogenated lecithin 0.75 0.75 0.75 0.75 0.75 Carbomer 0.3 0.3 0.3 0.3 0.3 Ammonium polyacryloyldimethyl taurate 0.2 0.2 0.2 0.2 0.2 Chelating agent 0.17 0.17 0.17 0.17 0.17 Antioxidant 0.5 0.5 0.5 0.5 0.5 pH adjuster 0.03 0.03 0.03 0.03 0.03 The composition of Inventive Examples 3 to 6 represents compositions according to the present invention. The composition of Comparative Example 5 does not include the liquid solvent according to the present invention. Preparation process: The compositions comprising the components listed in Table 4 were prepared as follows: 1. Add half the total quantity of demineralized water to a beaker, and heat the beaker to 75 °C using a water bath; 2. Addition of hydrogenated lecithin and thorough stirring; 3. Addition of cocos nucifera (coconut) oil only or of the mixture of cocos nucifera (coconut) oil and the chosen solvent (dipropylene glycol or octyldodecanol), homogenization at 75 °C at an agitation speed of 1000 rpm for 3 minutes; 4. Lowering the water bath temperature from 75°C to 40°C, adding the other half of the total amount of demineralized water, adding the remaining polymer ingredients (carbomer and ammonium polyacryloyldimethyl taurate), stirring thoroughly until a homogeneous emulsion is formed; 5. Addition of a chelating agent to the beaker and thorough stirring; 6. Addition of an antioxidant; 7. Adding a pH corrector to correct the pH = 5.1 + 0.3; and 8. Add a small amount of water to compensate for the water that evaporated during preparation. Assessment
[0112] The odor of each composition obtained was evaluated by nose by an odor expert and classified according to the standard mentioned above.
[0113] The evaluation results of each composition tested have been summarized in Table 5.
[0114] [Tableaux5] Components EI.3 EI.4 EI.5 El. 6 EC.5 Odor evaluation by nose Fair Good Good Excellent Poor
[0115] Table 5 shows that the rancid odor of the composition is of medium level to barely perceptible for the compositions of Inventive Examples 3 to 6.
[0116] The odor of each composition obtained was also evaluated by corridor tests.
[0117] Each series of corridor tests involved 10 volunteers identifying the odor of two samples. For comparison, one volunteer was asked to identify the sample with a lighter, more pleasant odor using their nose. The volunteer's response was then recorded and calculated as a percentage of the sample considered to have a lighter odor within the same group of two samples. Only the person who delivered the sample knew the specific content of the selected samples throughout the testing process. In the survey using the corridor tests, the five formulas (Ex. 3 to 6 and EC. 5) were classified into a range of groups to demonstrate the differences between them.
[0118] The results of the corridor tests are summarized in Table 6.
[0119] [Tableauxô] Group Results Ratio per 10 volunteers Winning formula with lighter scent Percentage supporting the winning formula EI.3 vs EC.5 8:2 EI.3 80% EI.4 vs EC.5 9:1 EI.4 90% EI.5 vs EC.5 9:1 EI.5 90% EI.6 vs EC.5 10:0 EI.6 100%
[0120] As can be seen in Tables 5 and 6, the results for the classification of the compositions of Inventive Examples 3 to 6 and Comparative Example 5 are substantially consistent with the results of the lane tests.
Claims
Claims
1. A composition for caring for keratinous materials, comprising: a) at least one liquid solvent selected from monoalcohols containing 6 or more carbon atoms, diols containing 4 or more carbon atoms and diol ethers containing 4 or more carbon atoms; and b) a fatty acid and ester mixture comprising i) a fatty acid component comprising at least 3 medium-chain fatty acids, and, ii) an ester component comprising at least 3 medium-chain fatty acid monoesters with a polyol, wherein the weight ratio of the liquid solvent to the fatty acid and ester mixture is greater than 1.5:1 and less than 25:
1.
2. Composition according to claim 1, wherein the liquid solvent is selected from caprylyl glycol, hexylene glycol, dipropylene glycol, octyldodecanol, isostearyl alcohol, ethoxydiglycol, and a combination thereof; preferably, the liquid solvent is selected from octyldodecanol, dipropylene glycol, hexylene glycol, caprylyl glycol and a combination thereof.
3. A composition according to any one of claims 1 or 2, wherein the mixture of fatty acid and ester comprises: i) a fatty acid component comprising at least 3, 4 or 5 medium-chain fatty acids; and ii) an ester component comprising at least 3, 4 or 5 monoesters of medium-chain fatty acids with a polyol, wherein the medium-chain fatty acid denotes a monocarboxylic acid having 6 to 20 carbon atoms, preferably 8 to 16 carbon atoms, and more preferably 8 to 12 carbon atoms.
4. A composition according to any one of claims 1 to 3, wherein the fatty acid component comprises at least 3 fatty acids selected from the group consisting of caprylic acid, capric acid, lauric acid, myristic acid, palmitic acid, stearic acid and arachidic acid, and the corresponding glycerides of each fatty acid in the fatty acid component are used as the monoester component, preferably, the fatty acid component comprises caprylic acid, capric acid and lauric acid, while the monoester component comprises monocaprylin, monocaprin and monolaurin, wherein the weight ratio of fatty acids in the fatty acid component to monoesters in the monoester component is from 4:1 to 1:1, preferably from 3:1 to 1:1, and more preferably from 2.5:1 to 1.5:
1.
5. A composition according to any one of claims 1 to 4, wherein the mixture of fatty acid and ester is activated virgin coconut oil comprising i) a fatty acid component comprising: caprylic acid in an amount of 5 to 20% by weight, preferably 7 to 15% by weight, and more preferably 8 to 10% by weight; capric acid in an amount of 1 to 10% by weight, preferably 2 to 8% by weight, and more preferably 4 to 7% by weight; and lauric acid in an amount of 20 to 70% by weight, preferably 30 to 60% by weight, and more preferably 40 to 55% by weight, and ii) a monoester component comprising: monocaprylin in an amount of 0.5 to 15% by weight, preferably 1 to 10% by weight, and more preferably 4 to 7% by weight; monocaprin in an amount of 0.1 to 10% by weight, preferably 1 to 8% by weight, and more preferably 3 to 5% by weight;and monolaurin in an amount of 10 to 40% by weight, preferably 15 to 35% by weight, and more preferably 20 to 30% by weight, each relative to the total amount of the fatty acid component and the monoester component.;
6. A composition according to any one of claims 1 to 5, wherein the mixture of fatty acid and ester is activated virgin coconut oil comprising: i) a fatty acid component comprising caprylic acid, capric acid and lauric acid, in an amount of 5 to 40% by weight, preferably 10 to 30% by weight, and more preferably 20 to 25% by weight; ii) a monoester component comprising monocaprylin, monocaprin and monolaurin, in an amount of 1 to 30% by weight, preferably 5 to 20% by weight, and more preferably 10 to 15% by weight; iii) a diester component comprising diglycerides of caprylic acid, capric acid and lauric acid, in an amount of 10 to 50% by weight, preferably 20 to 45% by weight, and more preferably 30 to 40% by weight; and iv) a triester component comprising triglycerides of caprylic acid, capric acid and lauric acid, in an amount of 10 to 70% by weight, preferably 15 to 50% by weight, and more preferably 20 to 30% by weight, each relative to the total amount of the activated virgin coconut oil.
7. A composition according to any one of claims 1 to 6, wherein the weight ratio of the liquid solvent to the mixture of fatty acid and ester is from 1.6:1 to 20:1, preferably from 1.6:1 to 15:
1.
8. A composition according to any one of claims 1 to 7, further comprising one or more selected from perfumes, antioxidants, chelating agents, preservatives, thickeners, emulsifiers and pH regulators.
9. A composition according to claim 1, comprising, based on the total weight of the composition: (a) from 20% by weight to 80% by weight of a liquid solvent selected from octyldodecanol, dipropylene glycol, hexylene glycol, caprylyl glycol and a combination thereof; and b) from 3% by weight to 30% by weight of an activated virgin coconut oil comprising, based on the total amount of the activated virgin coconut oil: i) 20 to 25% by weight of a fatty acid component comprising caprylic acid, capric acid and lauric acid; ii) 10 to 15% by weight of a monoester component comprising monocaprylin, monocaprin and monolaurin; iii) 30 to 40% by weight of a diester component comprising diglycerides of caprylic acid, capric acid and lauric acid; and iv) 20 to 30% by weight of a triester component comprising triglycerides of caprylic acid, capric acid and lauric acid, wherein the weight ratio of liquid solvent to fatty acid / ester mixture is greater than 1.6:1 and less than 15:
1.
10. Non-therapeutic method for caring for keratinous materials, comprising applying the composition according to any one of claims 1 to 9 to the keratinous materials.
Citation Information
Patent Citations
Modified coconut oils with broad antimicrobial spectrum
EP1973415A1
Stable, liquid emulsifiers on the basis of citrate esters and their use
US20230101832A1
Modified coconut oils with broad antimicrobial spectrum
WO2007067028A1
Composition for a topical application on the skin
WO2020208253A1
Composition for caring for keratin materials
WO2021134460A1
